NCT01478568View on ClinicalTrials.gov

To Evaluate the Effect of Mirabegron (YM178) on Blood Levels of Desipramine When They Are Taken Together

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Pharmacokinetics of MirabegronHealthy Subjects
Interventions
DRUG

mirabegron

oral

DRUG

desipramine

oral

Trial Locations (1)

75015

SGS Aster, Paris

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01478568 - To Evaluate the Effect of Mirabegron (YM178) on Blood Levels of Desipramine When They Are Taken Together | Biotech Hunter | Biotech Hunter